Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Original Paper
  • Published:

The Chfr mitotic checkpoint protein functions with Ubc13-Mms2 to form Lys63-linked polyubiquitin chains

Abstract

We recently described a novel checkpoint pathway that functions early in mitosis to delay chromosome condensation in response to microtubule poisons. The only gene implicated so far in this checkpoint pathway is chfr, whose protein product contains a RING domain and has ubiquitin ligase activity in vitro. The significance of this activity in vivo is unclear. A recent report suggested that the Chfr protein targets itself for proteasome-dependent degradation in mitotic cells through autoubiquitination. However, we observe that in mitosis Chfr exhibits a phosphorylation-dependent electrophoretic mobility shift with no change in overall protein levels. Further analysis of its ubiquitin ligase activity revealed that Chfr can catalyse the formation of noncanonical Lys63-linked polyubiquitin chains with Ubc13-Mms2 acting as the ubiquitin-conjugating enzyme. Ubc13-Mms2 and Lys63-polyubiquitin chains are not associated with targeting proteins to the proteasome, but rather with signaling cellular stress. We propose that Chfr may have a role in signaling the presence of mitotic stress induced by microtubule poisons.

This is a preview of subscription content, access via your institution

Access options

Buy this article

Prices may be subject to local taxes which are calculated during checkout

Figure 1
Figure 2
Figure 3
Figure 4
Figure 5

Similar content being viewed by others

References

  • Brusky J, Zhu Y and Xiao W . (2000). Curr. Genet., 37, 168–174.

  • Chaturvedi P, Sudakin V, Bobiak ML, Fisher PW, Mattern MR, Jablonski SA, Hurle MR, Zhu Y, Yen TJ and Zhou BB . (2002). Cancer Res., 62, 1797–1801.

  • Ciechanover A, Orian A and Schwartz AL . (2000). Bioessays, 22, 442–451.

  • Corn PG, Summers MK, Fogt F, Virmani AK, Gazdar AF, Halazonetis TD and El-Deiry WS . (2003). Carcinogenesis, 24, 47–51.

  • Deng L, Wang C, Spencer E, Yang L, Braun A, You J, Slaughter C, Pickart C and Chen ZJ . (2000). Cell, 103, 351–361.

  • Durocher D, Henckel J, Fersht AR and Jackson SP . (1999). Mol. Cell, 4, 387–394.

  • Durocher D, Taylor IA, Sarbassova D, Haire LF, Westcott SL, Jackson SP, Smerdon SJ and Yaffe MB . (2000). Mol. Cell, 6, 1169–1182.

  • Fang S, Jensen JP, Ludwig RL, Vousden KH and Weissman AM . (2000). J. Biol. Chem., 275, 8945–8951.

  • Hofmann RM and Pickart CM . (1999). Cell, 96, 645–653.

  • Honda R, Tanaka H and Yasuda H . (1997). FEBS Lett., 420, 25–27.

  • Honda R and Yasuda H . (2000). Oncogene, 19, 1473–1476.

  • Joazeiro CA, Wing SS, Huang H, Leverson JD, Hunter T and Liu YC . (1999). Science, 286, 309–312.

  • Kang D, Chen J, Wong J and Fang G . (2002). J. Cell Biol., 156, 249–259.

  • Levkowitz G, Waterman H, Ettenberg SA, Katz M, Tsygankov AY, Alroy I, Lavi S, Iwai K, Reiss Y, Ciechanover A, Lipkowitz S and Yarden Y . (1999). Mol. Cell, 4, 1029–1040.

  • Liao H, Byeon IJ and Tsai MD . (1999). J. Mol. Biol., 294, 1041–1049.

  • Lorick KL, Jensen JP, Fang S, Ong AM, Hatakeyama S and Weissman AM . (1999). Proc. Natl. Acad. Sci. USA, 96, 11364–11369.

  • Mizuno K, Osada H, Konishi H, Tatematsu Y, Yatabe Y, Mitsudomi T, Fujii Y and Takahashi T . (2002). Oncogene, 21, 2328–2333.

  • Pickart CM . (2001). Mol. Cell, 8, 499–504.

  • Scolnick DM and Halazonetis TD . (2000). Nature, 406, 430–435.

  • Shibata Y, Haruki N, Kuwabara Y, Ishiguro H, Shinoda N, Sato A, Kimura M, Koyama H, Toyama T, Nishiwaki T, Kudo J, Terashita Y, Konishi S, Sugiura H and Fujii Y . (2002). Carcinogenesis, 23, 1695–1700.

  • Stavridi ES, Huyen Y, Loreto IR, Scolnick DM, Halazonetis TD, Pavletich NP and Jeffrey PD . (2002). Structure, 10, 891–899.

  • Torres-Ramos CA, Prakash S and Prakash L . (2002). Mol. Cell. Biol., 22, 2419–2426.

  • Ulrich HD and Jentsch S . (2000). EMBO J., 19, 3388–3397.

  • Wang C, Deng L, Hong M, Akkaraju GR, Inoue J and Chen ZJ . (2001). Nature, 412, 346–351.

  • Wang P, Byeon IJ, Liao H, Beebe KD, Yongkiettrakul S, Pei D and Tsai MD . (2000). J. Mol. Biol., 302, 927–940.

  • Xiao W, Chow BL, Broomfield S and Hanna M . (2000). Genetics, 155, 1633–1641.

  • Zheng N, Wang P, Jeffrey PD and Pavletich NP . (2000). Cell, 102, 533–539.

Download references

Acknowledgements

We thank Peter Howley for the gift of plasmids expressing wheat E1, UbcH7 and UbcH8 and Frank Rauscher III and Philip Leder for their support and helpful discussions. This study was supported in part by the National Cancer Institute Grant CA89630 (to TDH); JB and MS were supported by National Cancer Institute Training Grants CA09171 and CA09677, respectively.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Thanos D Halazonetis.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Bothos, J., Summers, M., Venere, M. et al. The Chfr mitotic checkpoint protein functions with Ubc13-Mms2 to form Lys63-linked polyubiquitin chains. Oncogene 22, 7101–7107 (2003). https://doi.org/10.1038/sj.onc.1206831

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/sj.onc.1206831

Keywords

This article is cited by

Search

Quick links